期刊文献+

慢性乙型肝炎患者乙型肝炎病毒外膜大蛋白与病毒复制的相关性研究 被引量:11

Relativity between large protein of HBV membrane and virus replication in patients with HBV infection in Lanzhou
原文传递
导出
摘要 目的探讨慢性乙型肝炎病毒(HBV)感染患者血清乙型肝炎病毒外膜大蛋白(HBV-LP)与HBV-DNA、HBeAg之间的关系及临床应用价值。方法 2010年10月-2011年5月采用酶联免疫吸附法(ELISA)检测乙型肝炎病毒患者血清中HBV-LP,化学发光免疫分析法(CLIA)检测乙型肝炎病毒标志物(HBV-M),实时荧光定量PCR法(RT-PCR)检测HBV DNA载量,比较分析三者间的阳性率及相关性,数据采用SPSS17.0软件进行统计分析。结果 1 036例慢性HBV感染者中,HBV-LP阳性率为84.36%,较HBV-DNA阳性率72.01%与HBeAg阳性率54.44%均高,差异有统计学意义(P<0.01);HBV-LP与HBV-DNA和HBeAg的总符合率分别为78.19%、64.48%,HBV-LP与HBV-DNA和HBeAg阳性符合率分别为93.43%、94.86%;HBV-LP表达与HBV-DNA和HBeAg之间均显著关联(χ2=101.67,χ2=65.35),差异有统计学意义(P<0.01)。结论 HBVLP是反映HBV感染者体内复制程度的良好血清免疫学指标,血清中HBV-LP与HBV-DNA具有较好的相关性,特别是可作为HBeAg阴性患者检测病毒复制及预后判断的良好的指标。 OBJECTIVE To discuss the relationship between HBV-LP , HBV-DNA and HBeAg in patients with HBV infection in Lanzhou ,and its clinical application .METHODS ELISA ,CLIA and RT-PCR were used to detect HBV-LP ,HBV-M and HBV DNA ,respectively ,and the relativity between them was analyzed .The data were analyzed by SPSS17 .0 software .RESULTS In 1036 patients ,the positive rate of HBV-LP was 84 .36% ,higher than HBV DNA (72 .01% ) and HBeAg (54 .44% ) ,the difference was significant(P〈0 .01) .The total consistent rates of HBV-LP to HBV-DNA and HBeAg were 78 .19% ,64 .48% .The positive consistent rates of HBV-LP to HBV-DNA and HBeAg were 93 .43% ,94 .86% . HBV-LP expression with HBV-DNA and HBeAg showed significant correlation (χ2 = 101 .67 ,χ2 = 65 .35) ,and the difference was significant (P〈0 .01) .CONCLUSION HBV-LP is a good serum immune index of HBV replication in HBV infected patients , HBV-LP shows good relativity with level of HBV-DNA ,especially when using as an index of HBV replication and prognosis judgment in HBeAg negative serum patients .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第20期4976-4978,共3页 Chinese Journal of Nosocomiology
基金 兰州市科技局基金资助项目(2011-ZD-08)
关键词 慢性乙型肝炎病毒感染 乙型肝炎病毒外膜大蛋白 HBV-DNA 相关性 HBV chronic infection HBV-LP HBV DNA Relativity
  • 相关文献

参考文献8

  • 1Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infectinn[J]. Hepatology Research, 2010,40(1) : 31-48. 被引量:1
  • 2Philippe G,Isabelle C,Stephan U. Efficient inhibition of hepa titis B virus infection by aeylated peptides derived from the large viral surface protein[J]. J V iro, 2005,79 (3) : 1613- 1622. 被引量:1
  • 3谷茂林,王兴亮,吴婷婷.不同HBV标志物模式的乙型肝炎患者HBV表面大蛋白的检测及与HBV DNA水平的相关性[J].临床肝胆病杂志,2011,27(8):810-812. 被引量:3
  • 4贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3212
  • 5Chan HL, Wong VW, Hui AY, et al. Long-term lamivudine treatment is associated with a good maintained response in se- vere acute exacerbation of chronic HBeAg negative hepatitis B [J]. Antivir Ther,2006,11(4) :465-471. 被引量:1
  • 6Lambert C, Mann S,Prange R. Assessment of determinants af- fecting the dual topology of hepadnaviral large envelope pro- teins[J]. J Gen Virol,2004,85(pt5) :1221-1225. 被引量:1
  • 7Bangq KimK ll,Guamieri M,Zoulim F,et al. Effect of muta- ting the two cysteines required for HBe antigenicity on hepati- tis B virus DNA replication and virion secretion[J]. Virolog, 2005,332(1) :216-224. 被引量:1
  • 8Chua PK,Wang RY,Lin MH,e al. Reduced secretion of viri- ons and hepatitis B virus (HBV) surface antigen of anatural[y occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Gol- gi apparatus[J]. J Virol,2005,79(21):13483-13496. 被引量:1

二级参考文献27

共引文献3213

同被引文献85

  • 1Korkmaz H,Kesli R,Onder PB,et al. Assessment of evi- dence for positive association and seroprevalenee of hepa- titis B and C in diabetic patients in a developing country [J]. J Invest Med,2015,63(2) :251-257. 被引量:1
  • 2Turhanoglu M,Onur A,Bilman FB,et al. Eight-year sero- prevalence of HBV, HCV and HIV in diyarbakir training and research hospital[J]. Int J Med Sci, 2013, 10 ( 11 ) : 1595-1601. 被引量:1
  • 3Honge BL, Jespersen S, Medina C, et al. Hepatitis C prev- alence among HIV infected patients in Guinea-Bissau~ a descriptive cross-sectional study [J]. Int J Infect Dis, 2014,28(12) :35-40. 被引量:1
  • 4Krawczyk A, Hintze C, Ackermann J, et al. Clinical per formance of the novel DiaSorin LIAISON XL murex: HB- sAg Quant, HCV-Ab, HIV-Ab/Ag assays[J]. J Clin Vir- ol,2014,59(1) :44-49. 被引量:1
  • 5Rezaei M, Nooripoor S, Ghorbani R, et al. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan[ J]. J Prev Med Hyg, 2014, 55 (1) : 1 --3. 被引量:1
  • 6Korkmaz H, Kesli R, OnderPamuk B, et al. Assessment of evi- dence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country [ J ]. J Investig Med, 2015, 63(2) : 251 -257. 被引量:1
  • 7Krawczyk A, Hintze C, Ackermann J, et al. Clinical perform- ance of the novel DiaSorin LIAISON XL murex : HBsAg Quant, HCV - Ab, HIV - Ab/Ag assays [ J]. J ClinVirol, 2014, 59 (1) : 44 -49. 被引量:1
  • 8Turhanoglu M, Onur A, Bilman FB, et al. Eight - year sero- prevalence of HBV, HCV and HIV in Diyarbakir training and re- search hospital[ J]. Int J Med Sci, 2013, 10 (11) : 1595 - 1601. 被引量:1
  • 9Madalifiski K, Kolakowska A, Godzik P. Current views on the persistence of immunity following hepatitis B vaccination [ J ]. PrzeglEpidemiol, 2015, 69( 1): 47-51. 被引量:1
  • 10Varghese J, Sachan D, Reddy MS, et al. Hepatitis B immuno- globulin prophylaxis after liver transplantation: experience in a tertiary transplant centre [ J]. J ClinExpHepatol, 2014, 4 ( 3 ) : 209 -213. 被引量:1

引证文献11

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部